Doctors step into virtual exam room to test Genetic-Guided prescribing

NCT ID NCT02108041

First seen Oct 01, 2025 · Last updated May 16, 2026 · Updated 34 times

Summary

This study looked at how primary care doctors use genetic test results to decide on the right dose of a blood-thinner drug (warfarin) for virtual patients of different races and backgrounds. Nearly 200 doctors took part in a 60-minute virtual reality session. The goal was to understand how doctors incorporate personalized medicine into their decisions, not to treat any real patients.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Columbia University

    New York, New York, 10032-3784, United States

  • Harvard School of Public Health

    Boston, Massachusetts, 02115, United States

  • Johns Hopkins School of Medicine

    Baltimore, Maryland, 21205, United States

  • Michigan State University

    Flint, Michigan, United States

  • University of Oregon

    Eugene, Oregon, United States

Conditions

Explore the condition pages connected to this study.